Literature DB >> 3622549

Ketanserin and QTc prolongation.

B N Singh, K Nademanee, J Symoens, M Janssens.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1987        PMID： 3622549

Source DB:  PubMed          Journal:  Eur Heart J        ISSN： 0195-668X            Impact factor:   29.983


× No keyword cloud information.
  2 in total

Review 1.  Ketanserin. A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic potential in hypertension and peripheral vascular disease.

Authors:  R N Brogden; E M Sorkin
Journal:  Drugs       Date:  1990-12       Impact factor: 9.546

2.  Prevention of atherosclerotic complications: controlled trial of ketanserin. Prevention of Atherosclerotic Complications with Ketanserin Trial Group.

Authors: 
Journal:  BMJ       Date:  1989-02-18
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.